Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance
The environmental use of azole fungicides has led to selective sweeps across multiple loci in the Aspergillus fumigatus genome causing the rapid global expansion of a genetically distinct cluster of resistant genotypes. Isolates within this cluster are also more likely to be resistant to agricultural antifungals with unrelated modes of action. Here we show that this cluster is not only multi-azole resistant but has increased propensity to develop resistance to next generation antifungals because of variants in the DNA mismatch repair system. A variant in msh6-G233A is found almost exclusively within azole resistant isolates harbouring the canonical cyp51A azole resistance allelic variant TR<sub>34</sub>/L98H. Naturally occurring isolates with this msh6 variant display up to 5-times higher rate of mutation, leading to an increased likelihood of evolving resistance to other antifungals. Furthermore, unlike hypermutator strains, the G233A variant conveys no measurable fitness cost and has become globally distributed. Our findings further suggest that resistance to next-generation antifungals is more likely to emerge within organisms that are already multi-azole resistant due to close linkage between TR<sub>34</sub>/L98H and msh6-G233A, posing a major problem due to the prospect of dual use of novel antifungals in clinical and agricultural settings.
Authors
- Michael Bottery (ORCID: https://orcid.org/0000-0001-5790-1756)
- Harry Chown (ORCID: https://orcid.org/0000-0002-5331-4711)
- Johanna L. Rhodes (ORCID: https://orcid.org/0000-0002-1338-7860)
- Norman van Rhijn (ORCID: https://orcid.org/0000-0001-6722-2757)
- Michelle Momany (ORCID: https://orcid.org/0000-0001-7110-063X)
- Marin T. Brewer (ORCID: https://orcid.org/0000-0002-7064-6021)
- Brandi N. Celia-Sanchez (ORCID: https://orcid.org/0000-0002-8727-1262)
- Matthew C. Fisher (ORCID: https://orcid.org/0000-0002-1862-6402)
- Michael Bromley (ORCID: https://orcid.org/0000-0002-7611-0201)
- Christopher G. Knight (ORCID: https://orcid.org/0000-0001-9815-4267)
Institutions
- Radboud University Nijmegen (NL)
- University of Georgia (US)
- Manchester Academic Health Science Centre (GB)
- Radboud University Medical Center (NL)
- University of Manchester (GB)
- Imperial College London (GB)
- Medical Research Council (GB)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1038/s41467-024-54568-5
- Citations
- 32
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 12.45
Funders
- National Science Foundation
- U.S. Department of Agriculture
- Wellcome
- Wellcome Trust
- Sight Research UK
- Centers for Disease Control and Prevention
- Directorate for Biological Sciences
- National Institute of Food and Agriculture
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Natural Environment Research Council